Anterior gradient 2 induces resistance to sorafenib via endoplasmic reticulum stress regulation in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) accounts for almost 80% of all liver cancer cases and is the sixth most common cancer and the second most common cause of cancer-related death worldwide. The survival rate of sorafenib-treated advanced HCC patients is still unsatisfactory. Unfortunately, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hung-Wen, Chen, Yi-Li, Wang, Chun-I, Hsieh, Ching‑Chuan, Lin, Yang-Hsiang, Chu, Pei-Ming, Wu, Yuh-Harn, Huang, Yi-Ching, Chen, Cheng-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999520/
https://www.ncbi.nlm.nih.gov/pubmed/36899352
http://dx.doi.org/10.1186/s12935-023-02879-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999520/
https://www.ncbi.nlm.nih.gov/pubmed/36899352
http://dx.doi.org/10.1186/s12935-023-02879-w

Ejemplares similares